miR-592 is overexpressed in AD, which inhibits the antioxidant Keap1/Nrf2/ARE signaling pathway by downregulating its target gene KIAA0319, and promotes the oxidative stress injury of astrocytes in AD rat models. Here, KEAP1 is linked to Alzheimer disease.